As the first – and so far only – drug to enter clinical testing for the rare neurogenetic disorder Alexander disease, there were some unknowns heading into the readout of the pivotal study testing ...

Qure N.V. shares surge nearly 248% after its gene therapy candidate, AMT-130, met key goals in a pivotal Huntington's disease ...

A look into the statistics reveals the magnitude of the challenge ahead. In the last 20 Bundesliga encounters with Borussia Dortmund, Wolfsburg has managed only two draws and one win, while Dortmund ...

Actually, “assessment” is the correct term to use here, but using “testing” makes the title much more interesting. Language ...

The share of students proficient in math, English, and science is up for the first time since the pandemic - but passing ...

A relative newcomer has started to gain traction in the college-entrance-exam landscape—especially in red states.

How do we know which patients truly need this difficult treatment and which patients can safely skip it? The answer has arrived, delivered at the American Society for Radiation Oncology (ASTRO) 2025 ...

Baltimore is planning how to spend millions from opioid settlements, including on safe consumption sites, while other ...

Vulnerable patients with superbugs need antibiotics to work better, say doctors and scientists who are encouraged by an AI tool that invented new chemicals to treat drug-resistant gonorrhea and MRSA.

The U.S. government is on the brink of the first federal government shutdown in almost seven years, as Senate Democrats voted ...

At ASTRO, Artera presented clinical validation data on its prostate cancer test in an Asian population,and showed how the test may complement gene expression-based approaches.

The global driveline additive market is entering a period of unprecedented growth, projected to expand from USD 16.8 billion ...